// App-Quantinova.ai

PB0951 : Shortened Prothrombin Time and activated Partial Thromboplastin Time Tests as a Risk Factor for Venous or Arterial Thrombosis in Mexico

Researchers

Presenter

  • Y. Lee-Tsai

Principal Investigators

  • N/A

Medical Centers

  • Hosp General San Juan de Dios, Guatemala City, Guatemala

  • Unidad de Investigación Medica de Trombosis, Hemostasia y Aterogénesis. Instituto Mexicano del Seguro Social, Ciudad de Mexico, Distrito Federal, Mexico

  • Unidad de Investigación Medica de Trombosis, Hemostasia y Aterogénesis. Instituto Mexicano del Seguro Social, Ciudad de Mexico, Distrito Federal, Mexico

Locations

  • Guatemala

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Coagulation Factor III, Tissue Factor

  • Prothrombin

  • Activated partial thromboplastin time

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved